Details of the Drug

General Information of Drug (ID: DMLQTC9)

• Drug Name: NEXI-001

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 1/2	[1]
Myelodysplastic syndrome	2A37	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D0SZT3
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04284228) Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT. U.S. National Institutes of Health.